14 May 2026
Antibiotics Exceptional Reviewers List 2026
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are thrilled to share the updated 2026 Exceptional Reviewers List. This program was established to recognize and honor scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Antibiotics (ISSN: 2079-6382) acknowledges the vital role our reviewers play in maintaining the quality and integrity of the articles we publish. According to surveys conducted in 2025, 93% of our authors rated the peer review process as good or excellent, reflecting the strength and effectiveness of our reviewer community.
We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Antibiotics’s peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.
The Exceptional Reviewers List was introduced in April 2025. Each quarter, we will select a group of outstanding reviewers and introduce them here.
Q1
Name: Prof. Chyer Kim
Affiliation: Virginia State University, USA
Name: Prof. Madubuike Anyanwu
Affiliation: University of Nigeria, Nigeria
“As a scientific researcher, I consider manuscript reviewing an obligation rather than a choice, as the constructive criticisms I provide help safeguard the quality and integrity of science and also help me continually refine my research and writing skills. This recognition and award strengthen my commitment to engaging in more peer review activities.”
Name: Dr. Jianneng Yao
Affiliation: Kunming Medical University, China
Name: Dr. Olga Adriana Caliman-Sturdza
Affiliation: Stefan cel Mare University of Suceava, Romania
“Being a reviewer improves my scientific creativity, trains my critical spirit and stimulates me to be up to date with the latest news in my field. Also, through my activity as a reviewer, I strive to contribute to the academic activity and support colleagues in their research work through my feedback.”
Name: Dr. Aiken Dao
Affiliation: University of Sydney, Australia